title: Expression of transfected transforming growth factor alpha induces a motile fibroblast-like phenotype with extracellular matrix-degrading potential in a rat bladder carcinoma cell line.
abstract: Acquisition of cell motility is often correlated with the malignant progression of a transformed cell. To investigate some of the mechanisms involved in the development of a migratory state, we transfected the NBTII rat carcinoma cell line, which forms stationary epithelial clusters in culture, with the gene encoding human transforming growth factor alpha (TGF alpha). Expression of TGF alpha in NBTII cells resulted in cells of motile and vimentin-positive phenotype with internalized desmosomal components, analogous to the treatment of cells with exogenous TGF alpha. The clones expressed a 5.2-kb TGF alpha message and synthesized an 18-kDa form of TGF alpha. Supernatants of TGF alpha-producing clones induced the internalization of desmosomal components, the production of vimentin, and increased motility in untransfected epithelial NBTII cells, indicating that the factor produced by the clones was in a biologically active form. TGF alpha-producing clones secreted significant levels of a 95-kDa gelatinolytic metal-loproteinase, virtually absent in untransfected cell supernatants. In contrast, levels of inhibitors of metalloproteinases and of a plasminogen activator were similar in untransfected and TGF alpha-transfected NBTII cells. These results suggest that expression of TGF alpha in an epithelial tumor cell results in the development of a motile, fibroblast-like phenotype with matrix-degrading potential, which could result in a more aggressive tumor in vivo.
authors: Laboratoire de Physiopathologie du Développement, Centre National de la Recherche Scientifique, URA 1337, Ecole Normale Supérieure, Paris, France.
authors: J
authors: J
authors: Gavrilović
authors: G
authors: G
authors: Moens
authors: J P
authors: JP
authors: Thiery
authors: J
authors: J
authors: Jouanneau
mesh_terms: D000818:Animals; D015152:Blotting, Northern; D002454:Cell Differentiation / Q000187:drug effects*; D002461:Cell Line, Transformed / Q000187:drug effects; D005109:Extracellular Matrix / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D008666:Metalloendopeptidases / Q000378:metabolism; D010641:Phenotype; D010960:Plasminogen Activators / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D014162:Transfection; D015291:Transforming Growth Factors / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology*; D001749:Urinary Bladder Neoplasms / Q000378:metabolism* / Q000473:pathology; D014746:Vimentin
chemical_list: D012333:RNA, Messenger; D014746:Vimentin; D015291:Transforming Growth Factors; D010960:Plasminogen Activators; D008666:Metalloendopeptidases